Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 980.80
-3.95 (-0.40%)
At close: Mar 27, 2026
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 120.38 billion as of March 27, 2026. Its market cap has decreased by -7.73% in one year.
Market Cap
120.38B
Enterprise Value
114.46B
Revenue
25.12B
Ranking
n/a
PE Ratio
22.17
Stock Price
980.80
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 120.38B, an increase of 31.26%. That is a compound annual growth rate of 6.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 120.38B | 7.05% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 284.06B |
| Wockhardt | 193.28B |
| Piramal Pharma | 190.63B |
| Eris Lifesciences | 185.77B |
| NATCO Pharma | 175.29B |
| Alembic Pharmaceuticals | 132.40B |
| Cohance Lifesciences | 115.80B |
| Strides Pharma Science | 86.67B |